LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-0.40 Cr | ₹11 Cr | ₹-2.91 Cr | ₹-3.60 Cr | ₹-1.63 Cr |
What is the latest Cash Flow from Investing Activities ratio of LASA SUPERGENERICS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-0.40 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹-2.91 Cr |
Mar2021 | ₹-3.60 Cr |
Mar2020 | ₹-1.63 Cr |
How is Cash Flow from Investing Activities of LASA SUPERGENERICS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.40 Cr | Negative | |
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-2.91 Cr | Negative | |
Mar2021 | ₹-3.60 Cr | Negative | |
Mar2020 | ₹-1.63 Cr | - |
Compare Cash Flow from Investing Activities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹65.2 Cr | -12.1% | -23.6% | -35.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,868.0 Cr | 0.3% | -5.5% | 14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,010.0 Cr | 0.3% | 7.9% | 53.5% | Stock Analytics | |
CIPLA | ₹120,318.0 Cr | 1.7% | -1.3% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,644.0 Cr | 3.1% | 11.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,406.0 Cr | -1% | -4.4% | 16.3% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -12.1% |
-23.6% |
-35.5% |
SENSEX | -0.2% |
1% |
10.2% |
You may also like the below Video Courses